Vancouver, British Columbia, February 20, 2026 — Burcon NutraScience Corporation (the “Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to announce that all meeting matters put forth to shareholders, as voted on by shareholders, and where applicable, disinterested shareholders, were duly approved at its 2026…
Strong Q3 Revenue Growth Driven by Expanding Commercial Traction Vancouver, British Columbia, February 11, 2026 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, reported results for the fiscal third quarter ended December 31, 2025. “Fiscal Q3 marked an important milestone in Burcon’s commercial…
Vancouver, British Columbia, February 4, 2026 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, will be holding a special meeting (the “Meeting”) of shareholders at 10 am Pacific Time on February 20, 2026 held virtually via live webcast at https://meetnow.global/M97FRAF. Warrant Amendment Burcon…
Vancouver, British Columbia, January 28, 2026 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, February 11, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal 2026 third quarter…
Vancouver, British Columbia, January 9, 2026 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to announce that, in response to strong demand, it has increased the size of its previously announced non-brokered private placement (the “Private Placement”) of convertible debentures (the…
Vancouver, British Columbia, January 2, 2026 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the first tranche of a non-brokered private placement of convertible debentures (the “Convertible Debentures”) for an aggregate principal amount of up to…
Accelerating Demand Driving Strong Revenue Growth Vancouver, British Columbia, December 15, 2025 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to issue a letter to shareholders from its Chief Executive Officer, Kip Underwood. Dear Fellow Shareholders, 2025 was a transformational year…